StockData
EyePoint, Inc. logo

EyePoint, Inc. (EYPT) stock

EYPTNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$0.30−0.01 (-3.80%)

Close on Nov 17, 2026Market cap $25.51MP/E –Yield –

EyePoint r&d expenses

Research and development expenses are spending on new products and technology.

EyePoint's R&D Expenses for the twelve months ending Jun 30, 2026 was $262.73M, up 40.5% year over year. For fiscal 2025 it was $221.04M, up 66.3% from the year before. Over ten years it grew 36.9% a year on average. The highest annual figure on record is $221.04M in fiscal 2025.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$221.04M+66.3%
FY2024Dec 31, 2024$132.93M+105.6%
FY2023Dec 31, 2023$64.66M+30.3%
FY2022Dec 31, 2022$49.64M+74.2%
FY2021Dec 31, 2021$28.50M+63.6%
FY2020Dec 31, 2020$17.42M+7.7%
FY2018Jun 30, 2018$16.18M+8.7%
FY2017Jun 30, 2017$14.88M+3.5%
FY2016Jun 30, 2016$14.38M+19.0%
FY2015Jun 30, 2015$12.09M+26.3%
FY2014Jun 30, 2014$9.57M+36.7%
FY2013Jun 30, 2013$7.01M-0.5%
FY2012Jun 30, 2012$7.04M+2.5%
FY2011Jun 30, 2011$6.86M-1.9%
FY2010Jun 30, 2010$6.99M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q2 FY2026CQ2 2026Jun 30, 2026$83.61M+50.7%
Q1 FY2026CQ1 2026Mar 31, 2026$72.15M+23.2%
Q4 FY2025CQ4 2025Dec 31, 2025$59.21M+36.5%
Q3 FY2025CQ3 2025Sep 30, 2025$47.75M+61.6%
Q2 FY2025CQ2 2025Jun 30, 2025$55.50M+86.1%
Q1 FY2025CQ1 2025Mar 31, 2025$58.57M+94.3%
Q4 FY2024CQ4 2024Dec 31, 2024$43.37M+141.6%
Q3 FY2024CQ3 2024Sep 30, 2024$29.54M+70.1%
Q2 FY2024CQ2 2024Jun 30, 2024$29.82M+89.6%
Q1 FY2024CQ1 2024Mar 31, 2024$30.14M+121.3%
Q4 FY2023CQ4 2023Dec 31, 2023$17.95M+15.5%
Q3 FY2023CQ3 2023Sep 30, 2023$17.36M+55.6%
Q2 FY2023CQ2 2023Jun 30, 2023$15.73M+21.1%
Q1 FY2023CQ1 2023Mar 31, 2023$13.62M+36.9%
Q4 FY2022CQ4 2022Dec 31, 2022$15.54M+74.3%
Q3 FY2022CQ3 2022Sep 30, 2022$11.16M+31.3%
Q2 FY2022CQ2 2022Jun 30, 2022$12.99M+131.8%
Q1 FY2022CQ1 2022Mar 31, 2022$9.95M+81.5%
Q4 FY2021CQ4 2021Dec 31, 2021$8.92M+71.3%
Q3 FY2021CQ3 2021Sep 30, 2021$8.50M+107.8%
Q2 FY2021CQ2 2021Jun 30, 2021$5.61M+71.1%
Q1 FY2021CQ1 2021Mar 31, 2021$5.48M+12.9%
Q4 FY2020CQ4 2020Dec 31, 2020$5.21M+9.2%
Q3 FY2020CQ3 2020Sep 30, 2020$4.09M+23.0%
Q2 FY2020CQ2 2020Jun 30, 2020$3.28M-23.3%
Q1 FY2020CQ1 2020Mar 31, 2020$4.85M+27.1%
Q4 FY2018CQ2 2018Jun 30, 2018$4.77M+13.1%
Q3 FY2018CQ1 2018Mar 31, 2018$3.33M+0.0%
Q2 FY2018CQ4 2017Dec 31, 2017$4.27M+34.9%
Q1 FY2018CQ3 2017Sep 30, 2017$3.82M-8.6%
Q4 FY2017CQ2 2017Jun 30, 2017$4.21M+2.7%
Q3 FY2017CQ1 2017Mar 31, 2017$3.32M+8.1%
Q2 FY2017CQ4 2016Dec 31, 2016$3.17M-14.9%
Q1 FY2017CQ3 2016Sep 30, 2016$4.18M+20.0%
Q4 FY2016CQ2 2016Jun 30, 2016$4.10M+28.3%
Q3 FY2016CQ1 2016Mar 31, 2016$3.07M-7.9%
Q2 FY2016CQ4 2015Dec 31, 2015$3.72M–
Q1 FY2016CQ3 2015Sep 30, 2015$3.48M–
Q4 FY2015CQ2 2015Jun 30, 2015$3.20M–
Q3 FY2015CQ1 2015Mar 31, 2015$3.34M–

More EyePoint figures

See a number that looks wrong?